1. Home
  2. NPT vs CTSO Comparison

NPT vs CTSO Comparison

Compare NPT & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NPT

Texxon Holding Limited Ordinary shares

N/A

Current Price

$2.31

Market Cap

29.7M

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.42

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPT
CTSO
Founded
2011
1997
Country
China
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.7M
26.5M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
NPT
CTSO
Price
$2.31
$0.42
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
7.5M
212.6K
Earning Date
05-23-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$10.34
Revenue Next Year
N/A
$22.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$1.14
$0.37
52 Week High
$22.38
$1.23

Technical Indicators

Market Signals
Indicator
NPT
CTSO
Relative Strength Index (RSI) 49.20 41.86
Support Level $1.19 $0.37
Resistance Level $6.15 $0.72
Average True Range (ATR) 1.18 0.06
MACD 0.12 0.00
Stochastic Oscillator 9.00 21.63

Price Performance

Historical Comparison
NPT
CTSO

About NPT Texxon Holding Limited Ordinary shares

Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: